Resultado da Busca
any clinician seeking to apply or consult the nccn content, the nccn guidelines and/or any derivative resources is expected to use independent medical judgment in the context of the individual clinical circumstances to determine any patient's care or treatment.
2 de mar. de 2021 · This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Colon Cancer focuses on systemic therapy options for the treatment of metastatic colorectal cancer (mCRC), because important updates have recently been made to this section.
Colorectal Cancer Screening Distress During Cancer Care Esophageal Cancer Fatigue and Cancer Gallbladder and Bile Duct Cancers Gastrointestinal Stromal Tumors (GIST) Graft-Versus-Host Disease Hodgkin Lymphoma Hodgkin Lymphoma in Children Immunotherapy Side Effects: CAR T-Cell Therapy Immunotherapy Side Effects: Immune Checkpoint Inhibitors ...
Fight Colorectal Cancer (Fight CRC) is a leading patient-empowerment and advocacy organization providing balanced and objective information on colon and rectal cancer research, treatment, and policy.
The complete version of the NCCN Guidelines for Rectal Cancer, available online at NCCN.org, covers additional topics including risk assessment, pathology and staging, management of metastatic disease, posttreatment surveillance, treatment of recurrent disease, and survivorship.
Colorectal cancer (CRC) is the fourth most frequently diagnosed cancer and the second leading cause of cancer death in the United States. In 2016, an estimated 95,270 new cases of colon cancer and approximately 39,220 cases of rectal cancer will occur.
The NCCN Guidelines for Colon Cancer provide recommendations regarding diagnosis, pathologic staging, surgical management, perioperative treatment, surveillance, management of recurrent and metastatic disease, and survivorship.
